These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28585032)
1. Emerging role of echocardiography, cardiac magnetic resonance imaging and Massalha S; Ruddy TD J Nucl Cardiol; 2018 Dec; 25(6):2080-2083. PubMed ID: 28585032 [No Abstract] [Full Text] [Related]
2. The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy. Bianco M; Parente A; Biolè C; Righetti C; Spirito A; Luciano A; Destefanis P; Nangeroni G; Angusti T; Anselmino M; Montagna L J Nucl Cardiol; 2021 Jun; 28(3):825-830. PubMed ID: 33728572 [TBL] [Abstract][Full Text] [Related]
3. In the thick of it: hereditary cardiac amyloidosis identified by Smiley D; Einstein AJ; Chan N; Mintz A; Santana DD; Shetty M; Sekulic M; Goldner K; Wall J; Helmke S; Maurer MS J Nucl Cardiol; 2023 Jun; 30(3):1258-1262. PubMed ID: 37138173 [No Abstract] [Full Text] [Related]
4. Non-invasive detection and differentiation of cardiac amyloidosis using Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive risk stratification of patients with transthyretin amyloidosis. Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252 [TBL] [Abstract][Full Text] [Related]
6. Straightening out the wrinkles in technetium-99m-labeled bone scintigraphy tracer assessment of cardiac amyloidosis. Small GR; Ruddy TD J Nucl Cardiol; 2021 Feb; 28(1):100-103. PubMed ID: 30977095 [No Abstract] [Full Text] [Related]
7. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report. Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392 [TBL] [Abstract][Full Text] [Related]
9. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis. Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530 [TBL] [Abstract][Full Text] [Related]
10. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype. de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Kumamoto criteria for prediction of Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078 [TBL] [Abstract][Full Text] [Related]
12. Correlation of Quantitative Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L Heart Lung Circ; 2022 Jun; 31(6):804-814. PubMed ID: 35181228 [TBL] [Abstract][Full Text] [Related]